Care Bare Rx vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MEDVi beats Care Bare Rx overall, scoring 7.7/10 vs 7.4/10. MEDVi is more affordable at $179/mo vs $199/mo. Choose Care Bare Rx for users who prefer oral glp-1 pills and want a simple, no-appo. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at Care Bare Rx and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Care Bare Rx

#30 of 52

7.4/10

Simple GLP-1 provider offering oral pill options with a streamlined no-appointment-needed process.

Visit Care Bare Rx

Higher Rated

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Care Bare Rx	MEDVi
Our Score	7.4/10	7.7/10
Starting Price	$199/mo	$179/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who prefer oral GLP-1 pills and want a simple, no-appointment process	Users who want a low entry price with oral and injectable compounded options
Ranking	#30	#20
Get started	Visit Care Bare Rx	Visit MEDVi

Pros & Cons Compared

Care Bare Rx

Pros

+Both oral pill AND injectable GLP-1 options at the same flat $199/mo rate, flexibility to switch formats
+Named physician leadership (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) adds accountability
+Same price at every dose with no hidden fees, simple, transparent billing
+Free shipping included on all orders

Cons

−Founding date, headquarters, and pharmacy partners are not published. Ask which pharmacy fills your prescription before you order.
−Independent reviews are still very limited, so satisfaction and reliability are hard to verify. The named physician leadership is the main trust signal to weigh.
−Cash-pay only: no insurance accepted, and HSA/FSA eligibility isn't disclosed. Budget the $199/mo as a full out-of-pocket cost.

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

MEDVi edges out Care Bare Rx with a score of 7.7/10 vs 7.4/10. If budget is your priority, MEDVi starts at $179/mo compared to Care Bare Rx's $199/mo. Choose Care Bare Rx if you want: users who prefer oral glp-1 pills and want a simple, no-appointment process. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Care Bare Rx nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review